Design, synthesis and study of small molecules with both AR degradation and AKR1C3 inhibitory activities

被引：0
|
作者：
Xing, Enming [1 ]
Kong, Xiaotian [1 ]
Lou, Wei [2 ]
Shi, Ruihua [1 ]
Cheng, Xiaolin [1 ]
Gao, Allen C. [2 ]
Li, Pui Kai [1 ]
机构：
[1] Ohio State Univ, Coll Pharm, 500 W 12Th Ave, Columbus, OH 43210 USA
[2] Univ Calif Davis, Davis, CA 95616 USA
来源：
CANCER RESEARCH | 2020年 / 80卷 / 16期
关键词：
D O I：
10.1158/1538-7445.AM2020-5681
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
5681
引用
收藏
页数：2
相关论文
共 50 条
  • [41] Type 2 3a/Type 5 17β-HSD (AKR1C3) Is a Negative Regulator of Breast Cancer Proliferation: An Immunohistochemical and In Vitro Study
    Murugan, P.
    Lin, H-K
    Wu, W.
    Miller, V.
    Yang, Q.
    Fung, K-M
    LABORATORY INVESTIGATION, 2012, 92 : 55A - 55A
  • [42] Targeting backdoor androgen synthesis through AKR1C3 inhibition: A presurgical hormonal ablative trial in high risk localized prostate cancer (PC).
    Graham, Laura
    Reder, Nicholas
    Gulati, Roman
    Grivas, Petros
    Wright, Jonathan L.
    Yu, Evan Y.
    Hou, Wendy
    Nega, Katie
    Yezefski, Todd
    Montgomery, Robert B.
    Mostaghel, Elahe A.
    Ellis, William J.
    True, Lawrence D.
    Lin, Daniel W.
    Nelson, Peter
    Schweizer, Michael Thomas
    JOURNAL OF CLINICAL ONCOLOGY, 2019, 37 (15)
  • [43] Mesoporous silica nanoparticles combined with AKR1C3 siRNA inhibited the growth of castration-resistant prostate cancer by suppressing androgen synthesis in vitro and in vivo
    Chen, Junyu
    Yang, Yanrong
    Xu, Duo
    Li, Jing
    Wu, Shan
    Jiang, Yu
    Wang, Changshuai
    Yang, Zhaoyun
    Zhao, Lijing
    BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 2021, 540 : 83 - 89
  • [44] Targeting backdoor androgen synthesis through AKR1C3 inhibition: A presurgical hormonal ablative neoadjuvant trial in high-risk localized prostate cancer
    Graham, Laura S.
    True, Lawrence D.
    Gulati, Roman
    Schade, George R.
    Wright, Jonathan
    Grivas, Petros
    Yezefski, Todd
    Nega, Katie
    Alexander, Katerina
    Hou, Wen-Min
    Yu, Evan Y.
    Montgomery, Bruce
    Mostaghel, Elahe A.
    Matsumoto, Alvin A.
    Marck, Brett
    Sharifi, Nima
    Ellis, William J.
    Reder, Nicholas P.
    Lin, Daniel W.
    Nelson, Peter S.
    Schweizer, Michael T.
    PROSTATE, 2021, 81 (07): : 418 - 426
  • [45] Effect of insulin on AKR1C3 expression in female adipose tissue: in-vivo and in-vitro study of adipose androgen generation in polycystic ovary syndrome
    O'Reilly, Michael
    Gathercole, Laura
    Capper, Farfi A.
    Arlt, Wiebke
    Tomlinson, Jeremy
    LANCET, 2015, 385 : 16 - 16
  • [46] Biosynthesis and Degradation of Canine Placental Prostaglandins: Prepartum Changes in Expression and Function of Prostaglandin F2alpha-Synthase (PGFS, AKR1C3) and 15-Hydroxyprostaglandin Dehydrogenase (HPGD)
    Gram, Aykut
    Buechler, Urs
    Boos, Alois
    Hoffmann, Bernd
    Kowalewski, Mariusz P.
    BIOLOGY OF REPRODUCTION, 2013, 89 (01)
  • [47] Design, synthesis, cytotoxic and enzyme inhibitory activities of 1,3,4-oxadiazole and 1,3,4-thiadiazine hybrids against non-small cell lung cancer
    Ouf, Abdelsalam Mohamed Abdelsalam
    Allam, Heba Abdelrasheed
    Kamel, Marwa
    Ragab, Fatma A.
    Abdel-Aziz, Salah A.
    RESULTS IN CHEMISTRY, 2022, 4
  • [48] Exploring small molecules with pan-genotypic inhibitory activities against hepatitis C virus NS3/4A serine protease
    Ren, Jinhong
    Ojeda, Isabel
    Patel, Maulik
    Johnson, Michael E.
    Lee, Hyun
    BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2019, 29 (16) : 2349 - 2353
  • [49] Screening, synthesis, crystal structure, and molecular basis of 6-amino-4-phenyl-1,4-dihydropyrano[2,3-c]pyrazole-5-carbonitriles as novel AKR1C3 inhibitors
    Zheng, Xuehua
    Jiang, Zan
    Li, Xiaolin
    Zhang, Chen
    Li, Zhe
    Wu, Yinuo
    Wang, Xinhua
    Zhang, Chao
    Luo, Hai-bin
    Xu, Jun
    Wu, Deyan
    BIOORGANIC & MEDICINAL CHEMISTRY, 2018, 26 (22) : 5934 - 5943
  • [50] New 1,3,4-oxadiazole/oxime hybrids: Design, synthesis, anti-inflammatory, COX inhibitory activities and ulcerogenic liability
    Abd-Ellah, Heba S.
    Abdel-Aziz, Mohamed
    Shoman, Mai E.
    Beshr, Eman A. M.
    Kaoud, TamerS.
    Ahmed, Al-Shaimaa F. F.
    BIOORGANIC CHEMISTRY, 2017, 74 : 15 - 29
12345